Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BCSSBain Capital GSS Investment Corp.

NYSE · CIK 0002064355
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts52

Identity from submissions API

NameBain Capital GSS Investment Corp.
CIK0002064355
TickersBCSS, BCSS-UN, BCSS-WT
ExchangesNYSE, NYSE, NYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone6175162000
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
121 SOUTH CHURCH STREET
UGLAND HOUSE
GEORGE TOWN
KY1-1104
Cayman Islands
E9
Mailing address
200 CLARENDON STREET
BOSTON
MA
02116
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

41 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001193125-26-460644 001-42874 261552569 34 4149425 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349239 001-42874 261273638 34 4144395 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-006434 005-95273 26986601 34 13581
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001688382-26-000008 005-95273 26985042 34 10866
2026-05-14 10-Q 10-Q 0001193125-26-224313 001-42874 26980387 34 3527323 1 1
2026-03-20 10-K 10-K 0001193125-26-117644 001-42874 26778339 34 4670906 1 1
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-26-001997 005-95273 26640620 34 13693
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001688382-26-000003 005-95273 26639907 34 77648
2026-02-13 3 3 0001193125-26-051410 4470
2026-02-12 8-K 8-K 5.02,9.01 0001193125-26-048768 001-42874 26626402 34 190841 1 1
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000885 005-95273 26623648 34 16131
2025-12-22 3 3 0001193125-25-329104 4495
2025-12-22 4 4 0001193125-25-328932 6600
2025-12-19 8-K 8-K 5.02,9.01 0001193125-25-325746 001-42874 251585015 34 189918 1 1
2025-11-20 8-K 8-K 8.01,9.01 0001193125-25-288840 001-42874 251500969 34 197915 1 1
2025-11-14 10-Q 10-Q 0001193125-25-283130 001-42874 251487183 34 3147354 1 1
2025-10-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-240258 005-95273 251394930 34 6714
2025-10-07 8-K 8-K 8.01,9.01 0001193125-25-233659 001-42874 251380645 34 337965 1 1
2025-10-02 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001193125-25-227280 001-42874 251366389 34 1358962 1 1
2025-10-01 3 3 0001193125-25-227049 7742
2025-10-01 3 3 0001193125-25-227043 2919
2025-10-01 3 3 0001193125-25-227032 4507
2025-10-01 3 3 0001193125-25-226995 2881
2025-10-01 3 3 0001193125-25-226971 2930
2025-10-01 3 3 0001193125-25-226937 2927
2025-09-30 424B4 424B4 0001193125-25-225161 333-290126 251361150 33 1821173
2025-09-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003146 333-290126 251358016 33 1777
2025-09-29 CERT NYSE CERTIFICATION 0000876661-25-000714 001-42874 251352964 34 403697
2025-09-29 8-A12B 8-A12B 0001193125-25-221832 001-42874 251352452 34 15787
2025-09-25 CORRESP filename1.htm 0001193125-25-217461 6929
2025-09-25 CORRESP filename1.htm 0001193125-25-217452 7275
2025-09-17 CORRESP filename1.htm 0001193125-25-206059 23752
2025-09-17 S-1/A S-1/A 0001193125-25-206050 333-290126 251319776 33 3581493 1 1
2025-09-16 UPLOAD filename1.pdf 0000000000-25-010017 377-08103 45843
2025-09-09 CORRESP filename1.htm 0001193125-25-199207 19490
2025-09-09 S-1 S-1 0001193125-25-199062 333-290126 251302710 33 5432668 1 1
2025-08-11 UPLOAD filename1.pdf 0000000000-25-008400 377-08103 44024
2025-08-01 DRSLTR filename1.htm 0000950123-25-006899 20420
2025-08-01 DRS/A filename1.htm 0000950123-25-006897 377-08103 251175522 33 2912972
2025-07-10 UPLOAD filename1.pdf 0000000000-25-007290 377-08103 46694
2025-06-13 DRS filename1.htm 0000950123-25-006030 377-08103 251045077 33 2026016

Latest XBRL company facts

One latest value per concept from companyfacts (52 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-20 0001193125-26-117644
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 602,711 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 3.04M 2025-03-24 2025-12-31 2025 FY 10-K 2026-03-20 0001193125-26-117644
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap Assets Assets USD 478.54M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap AssetsCurrent Assets, Current USD 868,565 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 477.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap Cash Cash USD 622,015 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 622,015 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -162,934 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.5 2025-10-01 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 607,900 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-283130
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-283130
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 852,306 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 400,501 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 7,961 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 0.8 2025-10-01 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap Liabilities Liabilities USD 16.92M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 478.54M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap LiabilitiesCurrent Liabilities, Current USD 820,069 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 127,857 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -290,791 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 12.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -852,306 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap OtherIncome Other Income USD 13.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 9.00M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-283130
us-gaap OtherOwnershipInterestsOfferingCosts Other Ownership Interests, Offering Costs USD 735,700 2025-10-01 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 23.66M 2025-03-24 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 246,550 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 3.04M 2025-03-24 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 132,358 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 212,377 2025-03-24 2025-12-31 2025 FY 10-K 2026-03-20 0001193125-26-117644
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -16.05M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 9.00M 2025-03-24 2025-12-31 2025 FY 10-K 2026-03-20 0001193125-26-117644
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 6.00M 2025-10-01 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2025-10-01 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -16.05M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 25,000 2025-03-24 2025-03-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 4.45M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap TemporaryEquityValueExcludingAdditionalPaidInCapital Temporary Equity, Par Value USD 477.67M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 9.38M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460644
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.50M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-283130

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →